| 000 | 01474 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515004707.0 | ||
| 264 | 0 | _c20060124 | |
| 008 | 200601s 0 0 jpn d | ||
| 022 | _a0917-5857 | ||
| 024 | 7 |
_aCliCa05S-17579 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFujii, Naohiko | |
| 245 | 0 | 0 |
_a[Risedronate: a possible treatment for extraosseous calcification]. _h[electronic resource] |
| 260 |
_bClinical calcium _cSep 2005 |
||
| 300 |
_a75-8; discussion 78-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCREST Syndrome _xcomplications |
| 650 | 0 | 4 |
_aEtidronic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJoint Diseases _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOssification, Heterotopic _xdrug therapy |
| 650 | 0 | 4 |
_aOsteoporosis _xchemically induced |
| 650 | 0 | 4 |
_aPrednisolone _xadverse effects |
| 650 | 0 | 4 | _aRisedronic Acid |
| 650 | 0 | 4 | _aShoulder Joint |
| 700 | 1 | _aHamano, Takayuki | |
| 700 | 1 | _aIsaka, Yoshitaka | |
| 700 | 1 | _aIto, Takahito | |
| 700 | 1 | _aImai, Enyu | |
| 773 | 0 |
_tClinical calcium _gvol. 15 Suppl 1 _gp. 75-8; discussion 78-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/CliCa05S-17579 _zAvailable from publisher's website |
| 999 |
_c15897815 _d15897815 |
||